EVMN
Evommune, Inc.
6.70$
-3.9%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | +0.0% | -26.3% | +71.8% | -12.1% | +166.1% | +43.3% | -6.4% | |
| – | – | – | +0.0% | -26.6% | +74.7% | -14.8% | +89.9% | +40.6% | -5.4% | |
| – | – | – | +0.0% | -64.9% | +984.1% | -56.6% | +64.3% | +9.7% | +24.2% | |
| – | – | – | +0.0% | -32.8% | +79.3% | -12.4% | +96.2% | +41.7% | -5.0% | |
| – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | |
| – | – | – | +672.5% | -2.7% | +24.8% | +0.1% | -92.8% | -7.6% | +36.1% | |
| – | – | – | +0.0% | -21.2% | -54.2% | +3.2% | +71.9% | -40.8% | +64.9% | |
| – | – | – | -43.3% | +53.0% | -37.6% | +8.4% | +16.9% | +208.5% | -31.9% | |
| – | – | – | +0.0% | -8.4% | -51.5% | -2.6% | +116.9% | -47.8% | +24.7% | |
| – | – | – | +0.0% | -432.9% | – | – | – | +48.2% | -8.9% | |
| – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | – | – | +0.0% | +0.0% | +4.8% | +0.0% | +6.8% | +7.3% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.